CDK4和CDK6激酶:从基础科学到癌症治疗
Anne Fassl1, Yan Geng1, Piotr Sicinski1
1Department of Cancer Biology, Dana-Farber Cancer Institute, Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02215, USA.
基因酶4/6 (CDK4/6) 抑制剂是有效的癌症治疗方法. 新兴研究显示,这些抑制剂也影响瘤细胞代谢和免疫力,这表明治疗潜力更广.
科学领域:
- 癌症学
- 分子生物学
- 细胞循环调节
背景情况:
- 循环蛋白依赖性激酶4和6 (CDK4/6) 和D型循环蛋白调节细胞循环的进展.
- 构成性激活DCDK4/ 6是多种癌症的关键驱动因素.
- CDK4/ 6 抑制剂是激素受体阳性乳腺癌的已知治疗方法.
研究的目的:
- 审查最近关于细胞周期控制之外的CDK4/6生物学发现.
- 研究CDK4/ 6抑制对瘤细胞代谢和免疫力的影响.
- 讨论CDK4/6抑制剂在癌症治疗中的新疗法.
主要方法:
- 对CDK4/ 6抑制剂的最新研究的文献综述.
- 对受CDK4/6抑制影响的细胞功能数据的分析.
- 综合有关新兴治疗应用的信息.
主要成果:
- 抑制CDK4/ 6会影响瘤细胞的代谢.
- 抑制CDK4/6可以调节抗瘤免疫力.
- 这些效应表明CDK4/ 6抑制剂的作用扩大.
结论:
- 最近的进展加深了对CDK4/6生物学的理解.
- CDK4/6 抑制剂表现出超出已确定的适用范围的前景.
- 在瘤学中使用CDK4/6抑制剂的新疗法正在出现.
更多相关视频
11:11Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
Published on: February 21, 2019
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
相关概念视频
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity
Positive Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
